Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Iowa Medicine : Journal of the Iowa Medical Society
|
July 1, 1990
The cholesterol controversy
H Schrott, P Palumbo
Circulation
|
November 1, 1980
Strenuous physical activity, treadmill exercise test performance and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study
W L Haskell, H L Taylor, P D Wood, et al.
The American Journal of Cardiology
|
June 1, 1997
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I
M Davidson, J McKenney, E Stein, et al.
Diabetes Care
|
October 17, 1998
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, P E Hogan, S E Fineberg, et al.
Circulation
|
April 7, 1998
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, S M Marcovina, V Miller, et al.
The American Journal of Cardiology
|
May 1, 1993
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I
A M Gotto, W J Breen, C N Corder, et al.
Metabolism: Clinical and Experimental
|
October 4, 2000
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia
A S Dobs, H Schrott, M H Davidson, et al.
The American Journal of Medicine
|
April 5, 2001
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia
H H Knapp, H Schrott, P Ma, et al.
The Journal of Family Practice
|
December 3, 1998
Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease
D Hunninghake, R G Bakker-Arkema, J P Wigand, et al.
Atherosclerosis
|
June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
W Insull, M Koren, J Davignon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Iowa Medicine : Journal of the Iowa Medical Society
|
July 1, 1990
The cholesterol controversy
H Schrott, P Palumbo
Circulation
|
November 1, 1980
Strenuous physical activity, treadmill exercise test performance and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study
W L Haskell, H L Taylor, P D Wood, et al.
The American Journal of Cardiology
|
June 1, 1997
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I
M Davidson, J McKenney, E Stein, et al.
Diabetes Care
|
October 17, 1998
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, P E Hogan, S E Fineberg, et al.
Circulation
|
April 7, 1998
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
M A Espeland, S M Marcovina, V Miller, et al.
The American Journal of Cardiology
|
May 1, 1993
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I
A M Gotto, W J Breen, C N Corder, et al.
Metabolism: Clinical and Experimental
|
October 4, 2000
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia
A S Dobs, H Schrott, M H Davidson, et al.
The American Journal of Medicine
|
April 5, 2001
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia
H H Knapp, H Schrott, P Ma, et al.
The Journal of Family Practice
|
December 3, 1998
Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease
D Hunninghake, R G Bakker-Arkema, J P Wigand, et al.
Atherosclerosis
|
June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
W Insull, M Koren, J Davignon, et al.
Page
of 2